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Response to Editorial comments: 
We gratefully acknowledge your review of our manuscript. We fully recognize our good 
fortune at receiving your review because we know your fine work well. We modified the 
original manuscript based on your comments. Your e-mail of February 16: “In terms of 
incremental knowledge, your manuscript in its present form does not reach the standard of the 
journal. However, it would if the additional study was performed. Final editorial decision could 
be made readily after resubmission and will not require further reevaluation by the reviewers.” 
encouraged me greatly. 
Major criticisms: 
1) As suggested by the editor, we omitted the descriptions regarding the turbidity assay of 
vernix caseosa-surfactant TA mixture. Figure 3 and the Legend to Fig. 3 were completely 
omitted. Accordingly, the following figure was renumbered. 
2) We thank the editor for the kind suggestion. We performed the additional experiment to 
show that micelles derived from human amniotic fluid induce the detachment of vernix caseosa. 
The request from Dr. Sherin Devaskar has been solved during revision process.  
The last sentence of the Introduction section was rewritten as following: "We also 
performed experiments to show that a specific component of the surfactant; surfactant protein 
B (SP-B), is associated with the micelles, and that micelles derived from human amniotic fluid 
induce the detachment of vernix caseosa under in vitro condition." (page 6, line 7 to 10). In the 
Materials and Methods section, the sentences “Amniotic fluid samples of 15 ml were obtained 
by amniocenteses from four healthy Japanese pregnant women at term. The samples were 
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methodically fractioned by differential centrifugation (3, 15). The 22,500 x g sediments 
(micelle fractions) were dispersed with 1 ml of saline and subsequently added to each 1.5-ml 
polypropylene microfuge tube, interiorly coated with 10 mg of vernix caseosa (5). The samples 
from the vernix caseosa-saline mixtures (n = 4) were used as controls. Each sample was 
analyzed spectrophotometrically at 650 nm before and after overnight incubation at 37°C (5). 
The optical density correlated with solution turbidity that resulted from detachment of vernix 
from the walls of the microfuge tubes (5). Changes in absorbance values of micelle samples 
during overnight incubation were compared with those of control samples.” were added (page 
9, 10). The Results section (page 11, line 1 to 5) and the Discussion section (page 11, line 14, 
15) were modified. Figure 4 and the Legend to Fig. 4 were added.   
Additional points: 
1) The additional research, for which you asked us, needed an expert person. Our study has 
been accomplished by his joining. Accordingly, in the revised manuscript, his name, “Makoto 
Orisaka“, should be added to the author of our manuscript. All authors have agreed to that. 
2) We realize the limitation of our English. You can rewrite our original sentences for the 
readers of your journal, if necessary. All authors have agreed to that. 
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Abstract 
Studies using in vitro analysis have shown that the interaction between pulmonary 
surfactant and vernix caseosa could explain the appearance of amniotic fluid turbidity. 
That phenomenon is interpreted based on the “roll-up” hypothesis. We tested the roll-up 
hypothesis by examining the presence of micelles of pulmonary surfactant in human 
amniotic fluid at term. Amniotic fluid samples were collected from each of six healthy 
pregnant women at term and at 16 weeks of gestation. These samples were stained 
negatively and analyzed using an electron microscope. Ultrastructures present in 
amniotic fluid were compared with the structure of micelles derived from suspended 
surfactant TA isolated from bovine lung. Surfactant TA formed spheroidal and 
rod-shaped micelles 10–70 nm in diameter above the critical micelle concentration. 
Identical micelle particles were described in human amniotic fluid at term. In addition, 
surfactant protein B was identified in the micelle fraction of amniotic fluid. However, 
no micelles were found in human amniotic fluid taken at 16 weeks of gestation. Our 
results support the view that pulmonary surfactant could induce the detachment of 
vernix caseosa and increase the turbidity of the amniotic fluid. 
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Introduction 
The turbidity of the amniotic fluid increases with gestational age during the third 
trimester (1–5). Studies using in vitro analysis have shown that the interaction between 
pulmonary surfactant and vernix caseosa could explain the appearance of amniotic fluid 
turbidity (5). Narendran et al. (5) speculated that pulmonary surfactant induces a 
“roll-up” phenomenon that leads to detachment of vernix caseosa from the fetal skin 
surface. Droplets of oil rise from the oil/substrate interface when the surfactant 
displaces the oily masses from the substrate in aqueous media. This displacement is 
called “roll-up” and is strictly controlled by micellization process kinetics (6, 7).  
Surfactants are chemical amphipathic compounds; they contain both 
hydrophobic and hydrophilic ends (8). They form micelles according to their critical 
micelle concentration (CMC) in an aqueous environment (8). Pulmonary surfactant, a 
mixture of specific phospholipids and apoproteins, is a natural surface-active agent (1, 
2). Pulmonary surfactant could thereby form micelles in human amniotic fluid. 
Numerous studies using electron microscopy have revealed pulmonary surfactant in 
amniotic fluid as a storage medium: lamellar body (2, 3). However, to our knowledge, 
no studies have investigated micelles of pulmonary surfactant. 
To test the roll-up hypothesis proposed by Narendran et al. (5), we used electron 
microscopy to determine the presence of micelles of alveolar surfactant in human 
amniotic fluid at term. Since impurities in amniotic fluid disturb ultrastructural analysis, 
we first analyzed micelles derived from surfactant TA (Surfacten®; Mitsubishi Pharma 
Corp., Osaka, Japan) for pattern recognition. We then analyzed mixtures of surfactant 
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TA and vernix caseosa and samples of amniotic fluid collected at term or at 16 weeks of 
gestation. We also performed experiments to show that a specific component of the 
surfactant; surfactant protein B (SP-B), is associated with the micelles, and that 
micelles derived from human amniotic fluid induce the detachment of vernix caseosa 
under in vitro condition. 
Materials and Methods 
Preparation of surfactant TA 
The composition of surfactant TA, which is isolated from bovine lung and used 
clinically (9), is similar to Survanta® (Ross Laboratories, Columbus, OH). It comprises 
83.5% phospholipids, 7.0% free fatty acids, 7.0% triglycerides, 1.0% hydrophobic 
surfactant-associated protein, and other components (10). First, we determined the 
CMC of surfactant TA in a physiological saline solution by measuring its surface 
tension with a Wilhelmy-type surface-tension meter (CBVP A-1; Kyowa Interface 
Science Co., Tokyo, Japan). A stock solution of surfactant TA was prepared by 
dissolving 108 mg of surfactant TA into saline and diluting it to 50 ml with saline 
solution. The stock solution was diluted accurately to determine the surface tension of 
surfactant TA. The value of the CMC of surfactant TA was obtained from the 
concentration/surface-tension curve (11, 12). Surfactant TA was suspended in a 
physiological saline solution at 37°C to analyze micelles. The surfactant TA solution 
was adjusted with a phospholipid concentration of 25, 50, 75, 100, 150, 200, or 500 
μg/ml. Samples were maintained at 37°C until electron microscopic analysis. 
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Preparation of vernix caseosa-surfactant TA mixture 
Samples were prepared according to the procedure of Narendran et al. (5). Briefly, 
vernix caseosa was harvested from full-term infants who were free of any antenatal 
complications, and stored in sterile vials at the time of delivery. Samples were 
refrigerated at -80°C until experiments. We applied 10 mg of vernix caseosa pooled 
from three term infants to the interior walls of 1.5-ml polypropylene microfuge tubes 
and spread it on the wall using a glass pestle to form an even coating. Then 1 ml of 
normal saline with 150 μg phospholipid derived from surfactant TA was added to the 
tubes. The mixture was agitated gently by slow rotation on a rotisserie/shaker 
(Labquake®; Barnstead/Thermolyne Corp., Dubuque, IA). The rotisserie was placed 
overnight in a thermally equilibrated room at 37°C. The liquid was decanted and 
subsequently analyzed electron microscopically. 
Preparation of amniotic fluid samples
Amniotic fluid samples were collected from six healthy Japanese women at term 
(≥37-wk gestation) singleton pregnancies. All six had been scheduled for elective 
cesarean delivery. In addition, we studied six healthy pregnant women at 16 weeks of 
gestation who had been scheduled for transabdominal amniocentesis for fetal 
chromosome analysis. Patients were excluded if they had a chronic or acute physical 
illness, or if they were taking medications at the time of enrollment. Informed consent 
was obtained from each subject before this study. The Institutional Review Board of the 
University of Fukui approved this study.  
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Details of the procedure are the following: amniotic fluid samples of 15 ml were 
obtained using amniocenteses; the samples were fractioned by differential 
centrifugation according to the methods described by Hook et al. (3). Each amniotic 
fluid sample was centrifuged at 370 x g for 10 min to remove the sediment; which 
consisted mainly of cells. Subsequently, the supernatant was centrifuged at 9,200 x g
for 20 min. The 9,200 x g supernatants were maintained at 37°C until analysis of 
micelles. 
Analysis of micelles
All samples for electron microscopy were stained negatively using 2% phosphotungstic 
acid at pH 7.2 (13, 14) and analyzed within 1 h after sample preparation. Electron 
micrographs were viewed at 75 kV using an electron microscope (H-7100 FA; Hitachi, 
Tokyo). 
Identification of SP-B in the micelle fraction of term amniotic fluid  
The presence of SP-B in the micelle fraction was examined by using Western blot 
analysis (15). Briefly, 15 ml of the 9,200 x g supernatant sample retrieved from term 
pregnancy was centrifuged at 22,500 x g for 30 min (4°C). Half of the resultant pellet 
was dispersed with 100μl of saline and maintained at 4°C until analysis of micelles. The 
remaining pellet was used for Western blot analysis: solubilized in 60 μl of gel sample 
buffer, boiled for 5 min, and separated using a 15% acrylamide SDS–PAGE gel. 
Electrophoresed samples were transferred to a nitrocellulose membrane (Trans-Blot®
Transfer Medium; Bio-Rad Laboratories, Inc, Hercules, CA) following the instructions 
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provided by the manufacturer. Immunoblotting was performed using a horseradish 
peroxidase system (Santa Cruz Biotechnology, Inc, Santa Cruz, CA) and bands were 
visualized by enhanced chemiluminescence according to the ECL Western Blotting 
Detection System (Amersham, Buckinghamshire, UK). A 1:5,000 dilution of mouse 
anti-human SP-B monoclonal antibody (clone 1BQ, subclass IgG2b; Chemicon 
International, Inc, Temecula, CA) was used as the primary antibody. The secondary 
antibody consisted of a 1:2,000 dilution of horseradish peroxidase–conjugated goat 
antimouse IgG (Santa Cruz Biotechnology).  
Turbidity assay of mixtures of vernix caseosa and amniotic fluid micelles
Amniotic fluid samples of 15 ml were obtained by amniocenteses from four healthy 
Japanese pregnant women at term. The samples were methodically fractioned by 
differential centrifugation (3, 15). The 22,500 x g sediments (micelle fractions) were
dispersed with 1 ml of saline and subsequently added to each 1.5-ml polypropylene 
microfuge tube, interiorly coated with 10 mg of vernix caseosa (5). The samples from 
the vernix caseosa-saline mixtures (n = 4) were used as controls. 
Each sample was analyzed spectrophotometrically at 650 nm before and after 
overnight incubation at 37°C (5). The optical density correlated with solution turbidity 
that resulted from detachment of vernix from the walls of the microfuge tubes (5). 
Changes in absorbance values of micelle samples during overnight incubation were 
compared with those of control samples.
Statistical analysis 
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Data are expressed as mean ± standard deviation. Statistical analysis was performed 
using StatView software, version 5.0 (SAS Institute Inc., Cary, NC). The Student t-test 
was used for continuous variables. All statistical tests were two-sided and significance 
was defined as P < 0.05. 
Results 
The CMC value of surfactant TA obtained from the concentration/surface-tension curve 
was 80 μg/ml (Fig. 1). The value is converted to approximately 67 μg/ml in 
phospholipid concentration (10). Surfactant TA formed micelles above its CMC at 
phospholipid concentrations of 75, 100, 150 (Fig. 2A), 200, and 500 μg/ml. 
Vernix detached from the tube wall above the CMC of surfactant TA. Surfactant 
TA interacted with vernix caseosa and subsequently formed micelles (Fig. 2B).
Micelles were also detected in all but one 9,200 x g supernatants of human 
full-term amniotic fluid samples (Fig. 2C). In addition, Western blot analysis revealed 
the presence of SP-B in the micelle fraction of term amniotic fluid (Fig. 3A and B). 
However, no micelles were identified in human amniotic fluid samples harvested at 16 
weeks of gestation.  
Amniotic fluid micelles interacted with vernix caseosa and subsequently induced 
vernix detachment from the tube wall (Fig. 4). In contrast, for control samples, the
mixtures of vernix caseosa and physiological saline remained clear after overnight 
incubation. The increasing absorbance values at 650 nm for micelle samples and control 
samples were 0.496 ± 0.178 and 0.055 ± 0.017, respectively (P = 0.0027). 
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Discussion 
The major finding of our study was the presence of micelles in human full-term 
amniotic fluid. Narendran et al. (5) speculated that amniotic fluid turbidity is secondary 
to roll-up detachment of vernix caseosa induced by pulmonary surfactant. The roll-up 
phenomenon is intrinsically controlled by micellization process kinetics; the detergent 
aqueous solution starts to remove contaminants at or near the CMC and reach maximum 
detergency at concentrations greater than the CMC (6, 7). Moreover, micelle induces 
the dissolution of the mass contaminant from surfaces directly into the aqueous phase 
(6). The present study also showed that human amniotic fluid micelles induce 
detachment of vernix caseosa under in vitro condition. Our results provide a strong 
support for the hypothesis proposed by Narendran et al. (5). 
Micelle particles in term amniotic fluids are similar to the micelles derived from 
surfactant TA. We also demonstrated the association of SP-B with micelles of human 
amniotic fluid. SP-B is important for optimizing the surface active properties of 
pulmonary surfactant and is co-secreted with the surfactant (2). Accordingly, our results 
suggest that amniotic fluid micelles are associated with pulmonary surfactant.  
Secretion of pulmonary surfactant begins at 25–30-wk gestation (1, 2). In 
addition, detachment of the vernix caseosa from fetal skin into the amniotic fluid 
commences at 34-wk gestation (4). These chronological events fit with the results of the 
present study of the absence of micelles in all amniotic fluid samples taken at 16 weeks 
of gestation. The absence of micelles in amniotic fluid from 16-wk pregnancies is a 
further indication that pulmonary surfactant is associated with the micelles in the 
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full-term amniotic fluid. Micelles were not detected at term in one of our six amniotic 
fluid samples. Thus, the latter case points to the limitation of our procedure.  
Numerous studies have reported that the surface-active fractions in amniotic fluid 
originate from fetal lung (2, 3). Hook et al. (3) indicated that the lamellar bodies in 
amniotic fluid are pulmonary surfactants based on differential centrifugation of the 
amniotic fluid. Lamellar bodies containing concentric whorls of phospholipids are 
recognized as storage forms of pulmonary surfactant (2, 3, 16). However, Hook’s 
procedure is unsuitable for analysis of small lipid vesicles. Furthermore, the lamellar 
bodies range in size from 1 to 5 μm (3); they are sufficiently large to obscure micelles 
(10–70 nm). On the other hand, a negative staining method is useful for examining 
suspensions of small particles, including micelles (13, 14). Using such technique, we 
were able to identify the presence of micelles in the 9,200 x g supernatant fraction of 
human full-term amniotic fluid, which differed from the fraction of lamellar bodies. 
This finding suggests that micelles are not derived from lamellar bodies during the 
preparation of amniotic fluid sample. Rather, micelles are naturally present in human 
amniotic fluid.  
Micellization is an important step for postnatal lipid absorption because fat is 
insoluble in the aqueous environment of the small-intestinal lumen (1, 8). Micelles exist 
in amniotic fluid swallowed by the fetus and in human breast milk ingested by neonates. 
Numerous studies have shown that maturation of the fetal gastrointestinal tract is 
partially enhanced by swallowed amniotic fluid (1, 17). The fetal lung synthesizes and 
secretes much greater amounts of surfactant than are needed for air adaptation after 
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birth. The micelles in swallowed amniotic fluid might act as a promoter of fetal 
intestinal maturation. 
Visualization of the micelle particles in human amniotic fluid has not been 
reported previously. Our results support the view that pulmonary surfactant could 
induce the detachment of vernix caseosa, thus increasing the turbidity of the amniotic 
fluid. Although further studies are needed, our findings enhance our understanding of 
the physiologic interaction between lung development and skin development. 
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Figure legends 
Figure 1. Surface tension behavior of surfactant TA solutions. The inset shows a 
magnified image of the region of interest. Surface tension decreased from 70.8 to 28.8 
mN/m with increasing concentration of surfactant TA. The CMC represented the 
concentration at the intersection of the two lines of the concentration/surface-tension 
curve. The CMC value was 80 μg/ml. 
Figure 2. Negative stain electron micrograph of micelles. (A) Micrograph of surfactant 
TA solution at phospholipid concentration of 150 μg/ml. Micelles are visible against the 
stained background. The diameter of spheroidal and rod-shaped micelles ranges from 
10 to 70 nm. The average diameter of micelles derived from surfactant TA is 35.4 nm. 
(B) Micrograph of mixtures of vernix caseosa and surfactant TA. Micelles are visible 
similarly to surfactant TA solution (see Fig. 2A). The average diameter of micelles 
derived from the mixtures is 46.8 nm, which was not significantly different from the 
average diameter of surfactant TA micelles (P > 0.05). (C) Micrograph of human 
amniotic fluid at term. Despite their lower number, micelles are similar to surfactant TA 
solution (see Fig. 2A and 2B). Calibration bar: 100 nm. (original magnification: × 
200,000) 
Figure 3. Identification of SP-B in the micelle fraction of full-term amniotic fluid. (A) 
Negative stain electron micrograph of 22,500 x g sediments retrieved from human 
amniotic fluid at term. Micelle particles are visible (see Fig. 2). Calibration bar: 100 nm. 
Page 17
(original magnification: × 200,000) (B) Western blot analysis revealed 42-kilodalton 
pro-SP-B and 8-kilodalton mature SP-B in the micelle fraction of term amniotic fluid. 
The fraction of the lamellar bodies, which is rich in SP-B, was used as positive control.  
Figure 4. Series of images showing time-dependent detachment of vernix caseosa by 
amniotic fluid micelles (top) and physiological saline (bottom). The turbidity of vernix 
caseosa- amniotic fluid micelle samples increased significantly during overnight
incubation at 37°C (top left, pre-incubation; top right, post-incubation). In contrast, the
mixtures of vernix caseosa and physiological saline remained clear after overnight
incubation (bottom left, pre-incubation; bottom right, post-incubation).
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